KPV is an MC1R/MC3R agonist with completed Phase 2 human trials for inflammatory bowel disease, while KLOW is an MC4R agonist studied primarily in preclinical neuroinflammation models with no published human data as of 2026
It is found primarily in liver, kidney, and muscle
8 Peptide Stability & Storage GuidanceLyophilized vs reconstituted peptide handling: temperature, light and freeze-thaw considerations
"Finding new and better treatments is critically important to help people live healthier lives." References Nirupam M Srinivasan, Mehdi Farokhnia, Lisa A Farinelli, Anna Ferrulli, Lorenzo Leggio, GLP-1 Therapeutics and Their Emerging Role in Alcohol and Substance Use Disorders: An Endocrinology Primer, Journal of the Endocrine Society , Volume 9, Issue 11, November 2025, bvaf141,
It has been shown that the expression of NbGSTU4 was up-regulated by Bamboo mosaic virus (BaMV) in N